drugset / Trial / NCT06433011

The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism

NCT06433011

Recruiting 500 enrolled Thrombolex, Inc.
NaSingle-groupOpen-labelTreatment

Summary

To demonstrate the efficacy and safety of the 8F BASHIR™ .035 Endovascular Catheter and the 8F BASHIR™ S-B .035 Endovascular Catheter for the administration of pharmaco-mechanical catheter directed therapy using pulse sprays of r-tPA into the pulmonary arteries for the treatment of intermediate risk pulmonary embolism (PE).

Timeline

Start
2024-10-17
Primary completion
2028-04-25
Completion
2028-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic Other

Indications